Drug Profile
Research programme: TrkA receptor antagonists - VM Discovery
Alternative Names: VMD-902Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator VM Discovery
- Class Small molecules
- Mechanism of Action TrkA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Inflammation; Neuropathic pain; Pancreatic cancer; Prostate cancer; Psoriasis; Vascular restenosis